Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEAP THERAPEUTICS, INC. Director's Dealing 2017

Jan 24, 2017

35080_dirs_2017-01-23_156acf13-afff-4294-9c0e-887eedbc5a74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LEAP THERAPEUTICS, INC. (LPTX)
CIK: 0001509745
Period of Report: 2017-01-20

Reporting Person: HealthCare Ventures VIII, L.P. (10% Owner)
Reporting Person: HealthCare Partners VIII, L.P. (10% Owner)
Reporting Person: HealthCare Partners VIII, LLC (10% Owner)
Reporting Person: WERNER HAROLD R (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2618406 Direct

Footnotes

F1: 2,618,406 shares are held of record by HealthCare Ventures VIII, L.P. Christopher K. Mirabelli, James H. Cavanaugh, John W. Littlechild, Harold Werner and Augustine Lawlor (collectively, the "HCVVIII Directors") are the Managing Directors of HealthCare Partners VIII, LLC ("HCPVIII LLC"), which is the General Partner of HealthCare Partners VIII, L.P. ("HCPVIII"), which is the General Partner of HealthCare Ventures VIII, L.P. Each of the HCVVIII Directors, including Harold Werner, HCPVIII LLC and HCPVIII indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures VIII, L.P and disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities.